Intravenous Iron Replacement Therapy (Feraheme, Injectafer ...
Intravenous Iron Replacement Therapy ... two of the following intravenous iron therapies each (Note: Laboratory values should be obtained within 1 to 3 ... Without End Stage Renal Disease (ESRD) Feraheme and Injectafer are medically necessary when the following criteria are met: For initial therapy, all of the following: o Diagnosis of IDA and ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Shoulder Replacement Surgery (Arthroplasty)
www.uhcprovider.comShoulder Replacement Surgery (Arthroplasty) ... FDA-approved reverse shoulder replacement surgery devices are generally approved for gross rotator cuff deficiency. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional
Reserve, Replacement, Shoulder, Arthroplasty, Surgery, Reverse shoulder replacement, Shoulder replacement surgery
Coverage Summary - UHCprovider.com Home
www.uhcprovider.comThe benefit information in this Coverage Summary is based on existing national coverage ... Also see the Medicare Prescription Drug Benefit Manual,Chapter 6, ...
Manual, Prescription, Drug, Benefits, Summary, Coverage, Prescription drug benefit manual, Coverage summary
UnitedHealthcare Group Medicare Advantage …
www.uhcprovider.comUnitedHealthcare® Group Medicare Advantage (PPO) Plan Network Care Provider Quick Reference Guide Insurance coverage provided by or through UnitedHealthcare Insurance Company or its affiliates.
Network, Reference, Medicare, Care, Group, Plan, Provider, Quick, Advantage, Unitedhealthcare, Unitedhealthcare group medicare advantage, 174 group medicare advantage, Plan network care provider quick reference
NEUROMUSCULAR ELECTRICAL STIMULATION …
www.uhcprovider.comNeuromuscular Electrical Stimulation (NMES) (NCD 160.12) Page 2 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 08/09/2017
Electrical, Stimulation, Neuromuscular, Neuromuscular electrical stimulation, Mens
APREPITANT FOR CHEMOTHERAPY-INDUCED …
www.uhcprovider.comChemotherapy-induced nausea and vomiting (CINV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy
Induced, Chemotherapy, Aprepitant, Nausea, Chemotherapy induced nausea and, Aprepitant for chemotherapy induced
Clinical Performance Guideline Medical Fertility Solutions ...
www.uhcprovider.comClinical Performance Guideline Fertility Solutions Infertility Medical Necessity Guideline Purpose: To provide an understanding of infertility treatment, issues surrounding infertility surgery, and issues surrounding multiple embryo transfers among individuals faced with the potential loss of fertility.
EXTRACORPOREAL SHOCK WAVE TREATMENT (ESWT)
www.uhcprovider.comExtracorporeal Shock Wave Treatment (ESWT) Page 1 of 4 ... Extracorporeal shock wave therapy (ESWT), using either a high- or low-dose protocol or a radial wave, is considered not medically necessary for all indications, including but not limited to the treatment of:
Treatment, Shocks, West, Therapy, Waves, Extracorporeal, Extracorporeal shock wave therapy, Extracorporeal shock wave treatment
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.comPervasive Developmental Disorder and Autism Spectrum Disorder: Benefit Interpretation Policy (Effective 01/01/2018) 3 Proprietary Information of UnitedHealthcare.
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.compervasive developmental disorders include autism, Rett's disorder, childhood disintegrative disorder, Asperger's disorder, and unspecified pervasive developmental disorder. E. …
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Approval Date: October 10, 2018 - UHCprovider.com Home
www.uhcprovider.comRetinal Prosthesis Page 1 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/10/2018 Proprietary Information of UnitedHealthcare.
Related documents
ESPEN Guidelines on Enteral Nutrition: Adult Renal Failure
espen.infoassociated with renal failure and with the under-lying disease process and its associated complica-tions, but also the derangements in nutrient balances due to renal replacement therapies (RRTs). This is especially true when higher effi-ciency depurative techniques are used (continuous therapies such as continuous veno-venous haemo-
Guidelines, Replacement, Nutrition, Adults, Learn, Enteral, Therapies, Espen, Espen guidelines on enteral nutrition, Adult renal, Renal replacement therapies
ESPEN Guidelines on Parenteral Nutrition: Adult Renal Failure
espen.infoRenal replacement therapies have profound effects on metabolism and nutrient balances. C 2 Poor nutritional status is a major risk factor for morbidity and mortality, thus determining outcomes. B 3 (continued on next page)
Clinical Practice Guideline Haemodialysis - Renal
ukkidney.orgare aware of the interactions between renal replacement therapies and pregnancy which may impact on family planning and modality decisions. [1D] For dialysis patients wishing to continue their pregnancy, we recommend changing as early as possible to an individualised, augmented haemodialysis schedule.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govFeraheme is an iron replacement product indicated for the treatment of iron ... therapies are readily available for the treatment of hypersensitivity reactions [see Adverse Reactions (6.1)]. ... renal, or cardiac function, and of concomitant disease or other drug therapy
COMMUNITY HOSPITAL CARE
www.moh.gov.sgoccupational therapies) after the acute hospitals’ management and treatment for conditions such as stroke, joint replacement surgeries, fractures, and other types of surgeries. The community hospitals also . 4 ... Patients with renal conditions who are
Osteoarthritis: Diagnosis and Treatment
www.aafp.orgJan 01, 2012 · therapies. All patients with osteoarthritis ... Discuss total joint replacement for osteoarthritis of the hip, knee, or shoulder if steps below are unsuccessful ...
SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eureplacement, if indicated, continuation of pembrolizumab may be considered after corticosteroid taper, if needed. Otherwise treatment should be discontinued. Hypothyroidism Hypothyroidism may be managed with replacement therapy without treatment interruption. Hepatitis NOTE: for RCC patients treated with pembrolizumab in combination with ...
Product, Replacement, Summary, Characteristics, Summary of product characteristics